undefined undefined
NaN.000
NaN.00%
ARS Pharmaceuticals (SPRY) has issued an announcement. ARS Pharmaceuticals, Inc...
05-10 19:12
ARS Pharmaceuticals(SPRY.US):2024年Q1财报实现营收0美元,前值为2万美元;每股收益为-0.11美元,前值为-0.16美元,预期...
05-10 07:40
ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate.
05-10 05:29
Two of ARS Pharmaceuticals’ (NASDAQ:SPRY) more-than-10% owners,Sarina Tan...
04-25 22:30
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is possibly approaching a major achieve...
04-22 19:50
成分股Nurix Therapeutics收涨26.67%领跑,该公司宣布,与赛诺菲延长针对STAT6的研究项目;Lyell Immunopharma涨15....
04-10 05:26
Response addresses all additional requests in FDA CRL, including positive data from a repeat dose PK/PD study of neffy under nasal allergen challenge (NAC) conditions, and updated testing that detected no measurable
04-03 21:04
MINNEAPOLIS, April 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ:...
04-03 20:00
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
03-28 20:30
Ars Pharmaceuticals, Inc. (SPRY) has disclosed a new risk, in the Accounting &a...
03-23 14:01